Open AccessCombined Use of Bevacizumab + Interferon A-2 α in the Treatement of Patients with Disseminated Kidney Cancer in Comparison with an Active Monitoring Group
Author(s) -
К. Ш. Ганцев,
Andrey A. Khmelevskiy
Publication year - 2019
Publication title -
kreativnaâ hirurgiâ i onkologiâ
Language(s) - English
Resource type - Journals
eISSN - 2307-0501
pISSN - 2076-3093
DOI - 10.24060/2076-3093-2018-8-4-263-267
Subject(s) - bevacizumab , medicine , nephrectomy , kidney cancer , cancer , immunotherapy , kidney , retrospective cohort study , oncology , renal cell carcinoma , survival rate , surgery , chemotherapy , urology